Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.1%

1 terminated out of 47 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed with results

Key Signals

1 with results89% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (18)
P 1 (2)
P 2 (2)
P 4 (1)

Trial Status

Recruiting17
Not Yet Recruiting14
Completed8
Active Not Recruiting4
Enrolling By Invitation2
Terminated1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (47)

Showing 20 of 20 trials
NCT07314606Not ApplicableRecruiting

Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease

NCT06839820Not ApplicableActive Not Recruiting

Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease

NCT07089420CompletedPrimary

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

NCT07539077CompletedPrimary

Prevalence of Disorders of Gut-Brain-Interaction in Pediatric Patients With In-remission Inflammatory Bowel Disease

NCT07353853Not ApplicableRecruitingPrimary

Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease

NCT07335705RecruitingPrimary

Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients

NCT07471490Enrolling By InvitationPrimary

Specimen and Data Collection for a Novel Biomarker Combination for the Differential Diagnosis of Inflammatory Bowel Disease and Irritable Bowel Syndrome.

NCT07470502Not ApplicableRecruitingPrimary

MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease

NCT07444060Recruiting

Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease

NCT07385807Not Yet Recruiting

Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Outcomes With Patient With Inflammatory Bowel Disease

NCT06993272Not ApplicableActive Not Recruiting

Relaxation Music for Chronic Pain

NCT07373457Phase 1Recruiting

A Phase I Study of HW201877 in Healthy Subjects

NCT07289672Not ApplicableNot Yet Recruiting

Food Limitations In Crohn's Disease and Ulcerative coliTis

NCT07247994Not Yet RecruitingPrimary

Neurological Manifestations in Children Diagnosed With Inflammatory Bowel Disease

NCT07195123Not ApplicableRecruiting

Evaluation of the SMART IBD App in Pediatric IBD

NCT07240181Not Yet RecruitingPrimary

OPTImization of Inflammatory Bowel Disease Treatment Through Understanding of Gut VIRome Heterogeneity

NCT07230262Not ApplicableRecruitingPrimary

Trial Comparing Multiport RObotic and Laparoscopic Surgery for Elective Colorectal Resections in IBD Patients (ACRO-IBD)

NCT07168499Not ApplicableRecruitingPrimary

Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis

NCT07205549Not Yet RecruitingPrimary

Utilization of Musculoskeletal Ultrasound to Detect Subclinical Findings in IBD Patients

NCT07177157Phase 1Not Yet Recruiting

The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease Patients

Scroll to load more

Research Network

Activity Timeline